Researcher
Marc Peeters
- Disciplines:Endocrinology and metabolic diseases, Pediatrics and neonatology, Nursing
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Department of Internal medicine (Department)
Member
From1 Oct 2000 → 30 Sep 2018
Projects
1 - 1 of 1
- Differentiation of COX-2-dependent and -independent VEGF induction in mouse tumors and human colorectal carcinoma and its association with malignancy and sensitivity to anti-angiogenic therapyFrom1 Jan 2008 → 30 Dec 2013Funding: FWO research project
Publications
1 - 10 of 117
- High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib(2018)Volume: 36
Authors: Pashalina Kehagias, Caroline Vandeputte, Lieveke Ameye, Hakim El Housni, Amelie Deleporte, Karen Geboes, Thierry Delaunoit, Marc Peeters, Gauthier Demolin, Lionel D'Hondt, et al.
Number of pages: 1 - Circulating tumor DNA detects early response to regorafenib in advanced colorectal cancer(2018)Volume: 78
Authors: Pashalina Kehagias, Caroline Vandeputte, Lieveke Ameye, Hakim El Housni, Jean-Francois Laes, Amelie Deleporte, Karen Geboes, Thierry Delaunoit, Gauthier Demolin, Marc Peeters, et al.
Number of pages: 1 - Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC)(2017)Volume: 35
Authors: Erwin Woff, Pashalina Kehagias, Caroline Vandeputte, Tarek Kamoun, Thomas Guiot, Lieveke Ameye, Karen Geboes, Thierry Delaunoit, Gauthier Demolin, Marc Peeters, et al.
Number of pages: 1 - Children's International Polyposis (CHIP) study : a randomized, double-blind, placebo-controlled study of celecoxib in children with familial adenomatous polyposis(2017)
Authors: Carol A Burke, Robin Phillips, Manuela F Berger, Chunming Li, Margaret Noyes Essex, Dinu Iorga, Patrick M Lynch, the study site investigators, Catharina Dhooge, Marc Peeters
Pages: 177 - 185 - Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer : the SIRFLOX study(2014)
Authors: Peter Gibbs, Val Gebski, Mark Van Buskirk, Kenneth Thurston, David N Cade, Guy A Van Hazel, the SIRFLOX Study group, Karen Geboes, Marc Peeters
Number of pages: 1 - Regorafenib assessment guided by metabolic imaging in refractory advanced colorectal cancer (aCRC) : REGARD-C study(2014)Volume: 32
Authors: Alain Hendliz, Amélie Deleporte, Thierry Delaunois, Marc Peeters, Gauthier Demolin, Jos Janssens, Stephane Holbrechts, Raphaël Maréchal, Javier Carasco, Marc Van Den Eynde, et al.
Number of pages: 1 - Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study(2012)
Authors: R Maréchal, B Vos, M Polus, T Delaunoit, Marc Peeters, P Demetter, A Hendlisz, A Demols, D Franchimont, G Verset, et al.
Pages: 1525 - 1530 - The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study(2012)
Authors: Daphne Hompes, André D'Hoore, Eric Van Cutsem, Steffen Fieuws, Wim Ceelen, Marc Peeters, Kurt Van der Speeten, Claude Bertrand, Hugues Legendre, Joseph Kerger
Pages: 2186 - 2194 - Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal cancer xenograft model(2012)
Authors: Christel Vangestel, Christophe Van De Wiele, Gilles Mees, Koen Mertens, Steven Staelens, Chris Reutelingsperger, Patrick Pauwels, Nancy Van Damme, Marc Peeters
Pages: 135 - 147 - A phase II randomized study of combined infusional leucovorin sodium and 5-FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer(2012)
Authors: H Bleiberg, A Vandebroek, I Deleu, P Vergauwe, HR Kalantari, G D'Haens, M Paesmans, Marc Peeters, A Efira, Y Humblet
Pages: 14 - 21